Article Per Year (5 Year)
p-Index From 2020 - 2025
0.61
P-Index
This Author published in this journals
All Journal AVICENNA Proceeding of Bengkulu International Conference on Health
Nadia Pudiarifanti
Poltekkes Kemenkes Bengkulu
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
FAKTOR FAKTOR KEPATUHAN PADA PASIEN HIPERTENSI DI MASA PANDEMI COVID-19 Heti Rais Khasanah; Nadia Pudiarifanti
Avicenna: Jurnal Ilmiah Vol. 17 No. 3 (2022): Avicenna: Jurnal Ilmiah
Publisher : Public Health Department, Faculty of Health Science University Muhammadiyah Bengkulu

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36085/avicenna.v17i3.4215

Abstract

Background: Hypertension is a silent killer where the symptoms are very diverse in each individual and are almost the same as other diseases. The factors that affect the compliance of hypertensive patients in taking drugs are external factors and internal factors Objective: This study aims to determine the level of compliance in hypertensive patients in consuming antihypertensive drugs at the Bengkulu City Pharmacy. Method:This study used an observational method with sampling using consetutive sampling techniques where the data taken were those that met the inclusion criteria and exclusion criteria. Data collection is carried out by questionnaire. Result: showed that from 101 research samples, the results of the level of adherence to taking medicines for hypertensive patients with the categories of Obedient 65.30%, Moderately Obedient 25.70% and Non-Compliant 8.90%.  
HUBUNGAN PENGARUH KONDISI COVID-19 TERHADAP KEPATUHAN DAN KUALITAS HIDUP PASIEN DIABETES MELITUS YANG BERKUNJUNG KE APOTEK KOTA BENGKULU Nadia Pudiarifanti; Heti Rais Khasanah
Avicenna: Jurnal Ilmiah Vol. 18 No. 1 (2023): Avicenna: Jurnal Ilmiah
Publisher : Public Health Department, Faculty of Health Science University Muhammadiyah Bengkulu

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36085/avicenna.v18i1.4855

Abstract

Background: The COVID-19 pandemic can affect and change various sectors of life. One of the chronic diseases that can play a role as a weight for Covid-19 is Diabetes Mellitus. The condition followed by decrease visits by diabetes mellitus patients at health facilities. The COVID-19 pandemic has had a negative psychological impact on the community in the form of anxiety for most people, health workers, the elderly, and people with chronic diseases. The purpose of study were to determine the relationship between the Covid-19 pandemic and adherence to the quality of life of diabetes mellitus patients who visited the pharmacy. The tools used in this study were the compliance questionnaire and SF 36 questionnaire to see the patient's quality of life. Method : This research is non-experimental (analytic-descriptive) with a cross-sectional design. Data collected from 70 respondents who had been diagnosed with diabetes mellitus. Result : Based on the results of this study, the compliance of diabetic patients during the pandemic was 43 (61.4%) compliant respondents, 19 (27.1%) moderately compliant respondents, and 8 (11.4%) non-compliant respondents. Compliance is related to the educational status of the respondent in a p-value of 0.00. The good category quality of life of respondents was 58 (82.9%), while in the poor category were 12 (17.1%) respondents. Quality of life is also related to education status and age of respondents in p-values of 0.05 and 0.00. Conclusion : Based on the results above, it can be concluded that have relation between the compliance with quality of life of respondents with diabetes in Pandemic Covid-19 conditions with p value 0.00.  
DESCRIPTION OF CURRENT BLOOD SUGAR LEVELS IN SCHIZOPHRENIC PATIENTS UNDERGOING ANTIPSYCHOTIC THERAPY AT RSKJ SOEPRAPTO BENGKULU Honesty Salma Junisa; Zamharira Muslim; Nadia Pudiarifanti
Proceeding B-ICON Vol. 2 No. 1 (2023): Proceeding of The 3rd Bengkulu International Conference on Health (B-ICON 2023)
Publisher : Poltekkes Kemenkes Bengkulu

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33088/bicon.v2i1.205

Abstract

One of the treatments for schizophrenia patients with pharmacology is antipsychotic treatment. Long-term use of antipsychotic drugs can cause side effects in very serious metabolic disorders, such as the risk of obesity, diabetes, and dyslipidemia. The purpose of this study was to determine the description of blood glucose levels during schizophrenia patients undergoing antipsychotic therapy at RSKJ Soeprapto Bengkulu. This research method is descriptive with retrospective data collection on medical records of schizophrenia patients at RSKJ Soeprapto Bengkulu for the period 2022. The number of samples used was 86 schizophrenia patients undergoing antipsychotic therapy. The results of this study showed that most patients were male 68 patients, the age range was 36-45 years old with 26 patients, the longest use of antipsychotic therapy was 2 years with 28 people (33%), the body mass index in schizophrenia patients was normal body mass index with 56 people. The most common single antipsychotic use was Risperidone for as many as 36 patients, for the use of the most combination antipsychotics, Chlorpromazine-Risperidone was 8 patients, and all patients had normal blood glucose levels (100%). This study concludes that blood glucose levels during schizophrenia patients who use single and combined antipsychotic therapy show no increase in blood glucose levels.
Co-Authors Heti Rais Khasanah Honesty Salma Junisa Zamharira Muslim